Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

July 30, 2020

Cyclin D-CDK4/6 functions in cancer

Advances in Cancer Research
Xueliang GaoHaizhen Wang
July 28, 2020
Open Access

NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer

International Journal of Molecular Sciences
Hsin-Hua ChungYu-Lueng Shih
July 30, 2020
Review

Unraveling exhaustion in adaptive and conventional NK cells

Journal of Leukocyte Biology
Aimee M MerinoFrank Cichocki
August 1, 2020

LncRNA DLG2-AS1 as a Novel Biomarker in Lung Adenocarcinoma

Cancers
Alberto M ArenasPedro P Medina
July 30, 2020
Review
Open Access

Telomeres and Telomerase in the Development of Liver Cancer

Cancers
Lena In der StrothAndré Lechel
July 28, 2020
Review
Open Access

Senescence and Host-Pathogen Interactions

Cells
Daniel HumphreysTeresa Frisan
July 31, 2020
Review
Open Access

Targeting Epigenetic Modifications in Uveal Melanoma

International Journal of Molecular Sciences
Pooneh Chokhachi BaradaranBozena Smolkova
July 28, 2020
Open Access

BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression

Blood Advances
Thomas E C CumminMatthew J Carter
July 24, 2020
Open Access

Transition to naïve human pluripotency mirrors pan-cancer DNA hypermethylation

Nature Communications
Hemalvi PataniGabriella Ficz
July 30, 2020
Open Access

Tumor DNA hypomethylation of LINE-1 is associated with low tumor grade of breast cancer in Tunisian patients

Oncology Letters
Hayet Radia ZeggarMaher Kharrat
August 1, 2020

Clonal hematopoiesis in the inherited bone marrow failure syndromes

Blood
Frederick D Tsai, R Coleman Lindsley
August 2, 2020

Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden

Clinical Epigenetics
Robert F HillaryRiccardo E Marioni

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2020 Meta ULC. All rights reserved
/feed-previews/cancer-epigenetics-and-senescence/5947730c-0c12-4774-93cc-de874a1f59a8